Related Experiment Video
Updated: Jul 16, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Endogenous dopa in rat brain. Occurrence, distribution and relationship to changes i catecholamine synthesis
Naunyn-Schmiedeberg'S Archives of Pharmacology
|July 1, 1981
Summary
Dopa levels in rat brain are higher when rats are killed by microwave irradiation compared to decapitation. These basal dopa levels do not reflect catecholamine synthesis rates.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Dopa (L-3,4-dihydroxyphenylalanine) is a precursor to catecholamines.
- Understanding dopa's role in catecholamine synthesis is crucial for neurological research.
Purpose of the Study:
- To quantify and identify endogenous dopa in rat brain and plasma.
- To investigate the relationship between basal dopa levels and catecholamine synthesis.
Main Methods:
- Dopa isolation using cation exchange chromatography.
- Radioenzymatic assay with catechol-O-methyl-transferase and [3H]-S-adenosyl-methionine.
- Purification and identification via cation/anion exchange chromatography and thin-layer chromatography.
- Comparison of dopa levels in rats killed by decapitation versus microwave irradiation.
Main Results:
- Dopa concentrations were 7 ng/g in decapitated rats and up to 20 ng/g in microwave-irradiated rats.
- Dopa distribution in the brain mirrored catecholamine distribution, with highest levels in the striatum.
- Inhibition of tyrosine hydroxylase and administration of psychoactive drugs did not alter basal dopa levels.
Conclusions:
- The majority of brain dopa is in a slowly metabolized pool associated with catecholamine nerve terminals.
- A small, rapidly metabolized pool of dopa serves as a precursor for catecholamines.
- Basal dopa levels are not a reliable indicator of catecholamine synthesis rates.
More Related Videos
11:26Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Published on: September 21, 2017
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Related Concept Videos
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...